Preparing for medication discontinuation One of the biggest concerns with pharmaceutical GLP-1 medications is what happens when you stop
Supplementary Table 1 compares the hypothetical target trials and the emulated cohorts
Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, et al
Retatrutide, which would be Lilly's third obesity drug on the market if the Food and Drug Administration approves it, met both A1C- and weight-reduction goals in a Phase 3 trial of people with hard-to-control diabetes
Catecholamines DA and NE, precursor L-DOPA as well as catecholamine metabolites DOPAC and HVA were detected on a ThermoScientific Dionex UltiMate 3000 ECD-3000RS Electrochemical Detector (ThermoFisher Scientific) at 300 mV oxidation potential